| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190307 Assay |
| 08/04/2011 | US20110190303 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 08/04/2011 | US20110190300 Amide compounds and the use thereof |
| 08/04/2011 | US20110190296 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190290 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 08/04/2011 | US20110190279 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
| 08/04/2011 | US20110190276 Pyridine Derivatives And Their Use In The Treatment Of Psychotic Disorders |
| 08/04/2011 | US20110190267 Prodrugs of opioids and uses thereof |
| 08/04/2011 | US20110190266 5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) |
| 08/04/2011 | US20110190259 Compounds and compositions as protein kinase inhibitors |
| 08/04/2011 | US20110190258 Aryl benzylamine compounds |
| 08/04/2011 | US20110190249 Therapeutic methods and uses of sapogenins and their derivatives |
| 08/04/2011 | US20110190247 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 08/04/2011 | US20110190246 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 08/04/2011 | US20110190237 Macrocyclic Prodrug Compounds Useful as Therapeutics |
| 08/04/2011 | US20110190230 Betalain Compositions and Uses Thereof |
| 08/04/2011 | US20110190222 Selective Inhibition of Polyglutamine Protein Expression |
| 08/04/2011 | US20110190217 Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic epo short peptides |
| 08/04/2011 | US20110190216 Materials and methods for treatment of spinal muscular atrophy and taxane-induced peripheral neuropathy (tipn) |
| 08/04/2011 | US20110190215 Therapeutic use of peptides |
| 08/04/2011 | US20110190214 Advantageous Salts of Mu-Opiate Receptor Peptides |
| 08/04/2011 | US20110190213 Retro-inverso peptides derived from interleukin-3 |
| 08/04/2011 | US20110190212 Cyclic tetrapeptides |
| 08/04/2011 | US20110190210 Prominin-1 peptide fragments and uses thereof |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110189315 Plant extract and pufa combinations |
| 08/04/2011 | US20110189310 Small molecule modulators of prongf uptake |
| 08/04/2011 | US20110189308 Methods to treat neurodegenerative conditions or diseases by targeting components of a pten signaling pathway |
| 08/04/2011 | US20110189290 Compositions Comprising Capture Peptides for A B-Amyloid Peptide |
| 08/04/2011 | US20110189285 Hydrogel capable of containing and conveying cells |
| 08/04/2011 | US20110189280 Dosage form comprising 1-isopropyl-4-hexahydro-1h-1,4-diazepine or a salt thereof |
| 08/04/2011 | US20110189273 Amantadine compositions and methods of use |
| 08/04/2011 | US20110189272 Pharmaceutical preparation containing gabapentin |
| 08/04/2011 | US20110189263 Peptides that target dorsal root ganglion neurons |
| 08/04/2011 | US20110189259 Multidirectional mucosal delivery devices and methods of use |
| 08/04/2011 | US20110189239 Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same |
| 08/04/2011 | US20110189220 Mushroom compositions and methods for making and using |
| 08/04/2011 | US20110189212 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/04/2011 | US20110189211 Stem cell populations and methods of use |
| 08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
| 08/04/2011 | US20110189194 Use of cd95 inhibitors for the treatment of inflammatory disorders |
| 08/04/2011 | US20110189184 Modulation of neural stem cells and neural progenitor cells |
| 08/04/2011 | US20110189181 Use of agents derived from CEACAM1 for the treatment of inflammatory diseases |
| 08/04/2011 | US20110189165 Method of identifying disease risk factors |
| 08/04/2011 | US20110189161 Nutrigenomics methods and compositions |
| 08/04/2011 | US20110189157 Use of human hyaluronidases for axonal regrowth |
| 08/04/2011 | US20110189154 Applications For A New Class Of Enzymes: Sulfiredoxins |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189135 Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system |
| 08/04/2011 | US20110189134 Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same |
| 08/04/2011 | US20110189131 Active variants of the il-18 binding protein and medical uses thereof |
| 08/04/2011 | US20110189123 Mammalian cx3c chemokine antibodies |
| 08/04/2011 | US20110189097 Use of WNT inhibitor to inhibit angiogenesis in the CNS |
| 08/04/2011 | US20110189082 Human gm-csf antigen binding proteins |
| 08/04/2011 | CA2788326A1 Compounds for use in the treatment of diseases |
| 08/04/2011 | CA2788150A1 Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent |
| 08/04/2011 | CA2787785A1 Compositions and methods for enhancing proteasome activity |
| 08/04/2011 | CA2787321A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | CA2787315A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | CA2780421A1 Gamma secretase modulaters |
| 08/03/2011 | EP2351767A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
| 08/03/2011 | EP2351756A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351753A1 Phenanthroindolizidine derivative and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351751A1 Substituted pyrazolopyrimidines |
| 08/03/2011 | EP2351749A1 Carbamate compound or salt thereof |
| 08/03/2011 | EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 08/03/2011 | EP2351746A1 The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof |
| 08/03/2011 | EP2351737A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles |
| 08/03/2011 | EP2351586A1 Pharmaceutical compositions of active polypeptides for enhanced pharmacological activity through oral and parenteral administration |
| 08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 08/03/2011 | EP2351564A1 Methods of treating an inflammatory-related disease |
| 08/03/2011 | EP2351563A1 Agent for treatment of diabetes |
| 08/03/2011 | EP2351561A2 Novel methods and compositions for alleviating pain |
| 08/03/2011 | EP2350283A2 Compounds and methods for the treatment of inflammatory diseases of the cns |
| 08/03/2011 | EP2350093A1 Substituted 4,5,6,7-tetrahydrothienopyridines as kcnq2/3 modulators for treating pain, epilepsy and urinary incontinence |
| 08/03/2011 | EP2350092A1 Methylene amines of thieno ý2,3-d¨pyrimidine and their use as adenosine a2a receptor antagonists |
| 08/03/2011 | EP2350091A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 08/03/2011 | EP2350090A2 Spiro-oxindole compounds and their use as therapeutic agents |
| 08/03/2011 | EP2350088A1 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
| 08/03/2011 | EP2350072A1 Substituted pyrazoloquinolines and derivatives thereof |
| 08/03/2011 | EP2350051A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 08/03/2011 | EP2350042A1 Novel thiophene compounds for use in theraphy |
| 08/03/2011 | EP2350031A2 Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| 08/03/2011 | EP2350027A1 Tri-substituted pyrimidine compounds and their use as pde10 inhibitors |
| 08/03/2011 | EP2350023A1 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/03/2011 | EP2350015A1 Isoquinolinone derivatives as nk3 antagonists |
| 08/03/2011 | EP2350009A1 Sulfonate salts of flupirtine |
| 08/03/2011 | EP2350002A1 Novel compounds as calcium channel blockers |
| 08/03/2011 | EP2350000A1 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 08/03/2011 | EP2349998A2 A novel process for the preparation of eletriptan |
| 08/03/2011 | EP2349988A1 Organic nutrient salts, methods of preparation and uses |
| 08/03/2011 | EP2349308A1 Compounds for treatment of alzheimer's disease |
| 08/03/2011 | EP2349301A2 Use of a cinnamon bark extract for treating amyloid-associated diseases |
| 08/03/2011 | EP2349270A1 2,5-disubstituted morpholine orexin receptor antagonists |
| 08/03/2011 | EP2349269A1 2,5-disubstituted piperidine orexin receptor antagonists |